To examine the prevalence and profile of people with co-occurring mental and substance use disorders in relation to numerous demographic, diagnostic, and needs-related variables across a comprehensive system of mental health services using a standard methodology.
Method:
Data were collected on cases (n = 9839) sampled from specialty tertiary inpatient, specialty outpatient, and community-based mental health programs. Status with respect to co-occurring disorders was based on recorded diagnosis of substance use disorder and the substance abuse measure within the Colorado Client Assessment Record. The demographic and needs profile was compared across groups with or without co-occurring disorders within each level of care.
Results:
Overall, the prevalence of co-occurring disorders was 18.5%, and highest among clients receiving specialty tertiary inpatient care (28%), and within selected subpopulations such as younger adults (55%) and those with personality disorders (34%). There were few differences between groups based on co-occurring disorders in the specialty inpatient programs. For outpatient and community settings, the clients with co-occurring disorders were distinguished by a more impaired and complex needs profile and more likely to be young, single, male, and of low education. Across all levels of care, having a co-occurring disorder was strongly associated with antisocial and challenging behaviour, legal involvement, and risk of suicide or self-harm.
Conclusion:
The prevalence estimate of co-occurring disorders is likely representative of a multilevel system of care that serves a large, mixed urban and rural population. Results highlight the need to focus on specific subpopulations and sectors in pursuit of more integrated treatment and support for their mental health and addictions problems.
Health Canada. Best practices: Concurrent mental health and substance use disorders. Ottawa (ON): Health Canada; 2001.
2.
DrakeREBrunetteMF. Complications of severe mental illness related to alcohol and drug use disorders. In: GalanterM, editor. Recent developments in alcoholism: The consequences of alcoholism. New York (NY): Plenum Press; 1998. p 285–299.
3.
RachBeiselJScottJDixonL.Co-occurring severe mental illness and substance use disorders: A review of recent research. Psychiatr Serv. 1999;50(11):1427–1434.
4.
OsherFCDrakeRENoordsyDL, Correlates and outcomes of alcohol use disorders among rural outpatients with schizophrenia. J Clin Psychiatry. 1994;55(3):109–113.
5.
SchmidtL.A profile of problem drinkers in public mental health services. Hosp Community Psychiatry. 1992;43(3);245–250.
6.
ToddJGreenGHarrisonM, Social exclusion in clients with comorbid mental health and substance misuse problems. Soc Psychiatry Psychiatr Epidemiol. 2004;39:581–587.
7.
BarryKLFlemingMFGreenleyJR, Characteristics of persons with severe mental illness and substance abuse in rural areas. Psychiatr Serv. 1996;47(1):88–90.
8.
MueserKTRosenbergSDDrakeRE, Antisocial personality disorders and substance abuse in schizophrenia and major affective disorders. J Stud Alcohol. 1999;60:278–284.
9.
AngstJRSellaroRMerikangasKR. Multimorbidity of psychiatric disorders as an indicator of clinical severity. Eur Arch Psychiatry Clin Neurosci. 2002;252:147–154.
10.
McDermottWJMattiaJZimmermanM.Comorbidity burden and its impact on psychosocial morbidity in depressed outpatients. J Affect Disord. 2001;65:289–295.
11.
ReigerDAFarmerMERaeDS. Co-morbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiological Catchment Area (ECA) study. JAMA. 1990;264;2511–2518.
12.
KesslerRCNelsonCBMcConagleKA, The epidemiology of co-occurring addictive and mental disorders: Implications for prevention and service utilization. Am J Orthopsychiatry. 1996;66:17–61.
13.
KesslerRCChiuWTDemlerO, Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):617–627.
14.
GrantBFStinsonFSDawsonDA, Co-occurrence of 12-month alcohol and drug use disorders and personality disorders in the United States. Arch Gen Psychiatry. 2004;61:361–368.
15.
BroonerRKKingVLKidorfM, Psychiatric and substance use co-morbidity among treatment-seeking opioid abusers. Arch Gen Psychiatry. 1997;54:71–80.
16.
MueserKTYarnoldPRLevinsonDF, Prevalence of substance abuse in schizophrenia: Demographic and clinical correlates. Schizophr Bull. 1990;16:31–56.
17.
HienDZinbergSWeismanS, Dual diagnosis sub-types in urban substance abuse and mental health clinics. Psychiatr Serv. 1997;48:1058–1063.
18.
RossHEGlaserFBGermansonT.The prevalence of psychiatric disorders in patients with alcohol and other drug problems. Arch Gen Psychiatry. 1998;4:1023–1031.
19.
GalanterMCastenedaRFermanJ.Substance abuse among general psychiatric patients: Place of presentation, diagnosis and treatment. Am J Drug Alcohol Abuse. 1988;142:211–235.
20.
MyersPCortyEThompsonJ.Prevalence and patterns of “dual diagnosis” among psychiatric inpatients. Compr Psychiatry. 1994;35(2):267–271.
21.
KamaliMKellyLGervinM, The prevalence of comorbid substance misuse and its influence on suicidal ideation among in-patients with schizophrenia. Acta Psychiatr Scand. 2000;101(6):452–456.
22.
DixonLDibietzEMyersP, Comparison of DSM-III-R diagnoses and a brief interview for substance use among state hospital patients. Hosp Community Psychiatry. 1993;44(8):748–752.
23.
TonerBBShugarGCampbellB, Patterns of substance abuse in psychiatric inpatients. Can J Psychiatry. 1991;36:381–383.
24.
LehmanAFMeyersPCortyE, Prevalence and patterns of “dual diagnosis” among psychiatric inpatients. Compr Psychiatry. 1994;35(2):267–271.
25.
MueserKTYarnoldPRBellackAS. Diagnostic and demographic correlates of substance abuse in schizophrenia and major affective disorder. Acta Psychiatr Scand. 1992;85:48–55.
26.
MillingRNFaulknerLRCraigJM. Problems in the recognition and treatment of patients with dual diagnoses. J Subst Abuse Treat. 1994;11(3):267–271.
27.
HavassyBEAlvidrezJOwenKK. Comparisons of patients with comorbid psychiatric and substance use disorders: Implications for treatment and service delivery. Am J Psychiatry. 2004;161(1):139–145.
28.
TonerBBGilliesLAPrendergastP, Substance use disorders in a sample of Canadian patients with chronic mental illness. Hosp Community Psychiatry. 1992;43:251–254.
29.
FordLSnowdonLRWalserEJ. Outpatient mental health and the dual-diagnosis patient: Utilization of services and community adjustment. Eval Program Plann. 1991;14:291–298.
30.
EastbrookeSKrupaTHorganS, Substance abuse in a Canadian population of assertive community treatment (ACT) clients: Implications for service planning and delivery. Can J Nurs Res. 2003;35(1):44–51.
31.
OsherFCDrakeRENoordsyDL, Correlates and outcomes of alcohol use disorder among rural outpatients with schizophrenia. J Clin Psychiatry. 1994;55(3):109–113.
32.
DukePPantelisCBarnesT.South Westmister schizophrenia study: Alcohol use and its relationship to symptoms, tardive dyskinesia and illness onset. Br J Psychiatry. 1994;164:630–636.
33.
GrahamHlMaslinJCopelloA, Drug and alcohol problems amongst individuals with severe mental health problems in an inner city area of the UK. Soc Psychiatry Psychiatr Epidemiol. 2001;36:448–455.
34.
MenezesPJohnsonSThornicroftG, Drug and alcohol problems among individuals with severe mental illnesses in South London. Br J Psychiatry. 1996;168:612–619.
35.
RaskinVDMillerNS. The epidemiology of the comorbidity of psychiatric and addictive disorders: A critical review. J Addict Dis. 1993;12(3):45–57.
36.
MueserKTYarnoldPRLevinsonDF, Prevalence of substance abuse in schizophrenia: Demographic and clinical correlates. Schizophr Bull. 1990;16(1):31–56.
37.
SiegfriedN.A review of comorbidity: Major mental illness and problematic substance use. Aust N Z J Psychiatry. 1998;32(5):707–717.
38.
BuckleyPF. Substance abuse in schizophrenia: A review. J Clin Psychiatry. 1998;59(Suppl 3):26–30.
39.
MelartinTKRytsalaHJLeskelaUS, Current comorbidity of psychiatric disorders among DSM-IV major depressive disorder patients in psychiatric care in the Vantaa Depression Study. J Clin Psychiatry. 2002;63(2):126–134.
40.
VirgoNBennettGHigginsD, The prevalence and characteristics of co-occurring serious mental illness (SMI) and substance abuse or dependence in the patients of Adult Mental Health and Addiction Services in eastern Dorset. J Ment Health. 2001;10(2):175–188.
41.
SkinnerW.Treating concurrent disorders: A guide for counselors. Toronto (ON): Centre for Addiction and Mental Health; 2005.
42.
Center for Substance Abuse Treatment: Substance Abuse Treatment for Persons With Co-Occurring Disorders. Treatment Improvement Protocol (TIP) Series 42. DHHS Publication No (SMA) 05–3922. Rockville (MD): Substance Abuse and Mental Health Services Administration; 2005.
43.
KoeglCJDurbinJGoeringP.Mental health services in Ontario: How well is the province meeting the needs of persons with serious mental illness?Toronto (ON): Centre for Addiction and Mental Health; 2004.
44.
EllisRJWackwitzJHFosterM.Uses of an empirically derived client typology based on level of functioning: Twelve years of the CCAR. J Ment Health Adm. 1991;18:88–100.
45.
EllisRWilsonNFosterF.Statewide treatment outcome assessment in Colorado: The Colorado Client Assessment Record (CCAR). Comm Ment Health J. 1984;20:72–89.
46.
CoffmanJM. Assessing the validity of the Colorado Client Assessment Record for measurement of mental health status and outcomes. Poster presented at the 132nd Annual Meeting of the American Public Health Association; 2004 November; Washington (DC).
47.
SchwartzRC. Reliability and validity of the functional assessment rating scale. Psychol Rep. 1999;84:389–391.
48.
DurbinJCochraneJGoeringP, Needs-based planning: An evaluation of a level-of-care planning model. J Behav Health Serv Res. 2001;28:68–80.
49.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington (DC): APA; 1994.
50.
AnanthJVandewaterSKamalM, Missed diagnosis of substance abuse in psychiatric patients. Hosp Comm Psychiatry. 1989;40(3):297–301.
51.
BarnabyBDrummondCMcCloudA, Substance misuse in psychiatric inpatients: Comparison of a screening questionnaire survey with case notes. BMJ. 2003;327:783–784.
52.
CohenJ.Statistical power analyses for the behavioral sciences. 2nd ed. Hillsdale (NJ): Lawrence Erlbaum; 1988.
DrakeREWallachMN. Substance abuse among the chronically mentally ill. Hosp Comm Psychiatry. 1989;40(3):1041–1046.
55.
RushBRUrbanoskiKBassaniD, Prevalence of co-occurring substance use and other mental disorders in the Canadian population. Can J Psychiatry. 2008;53(12):800–809.
56.
KranzlerHRKaddenRMBaborTF, Longitudinal, expert, all data procedure for psychiatric diagnosis in patients with psychoactive substance use disorders. J Nerv Ment Dis. 1994;182:277–283.
57.
Substance Abuse and Mental Health Services Administration. Report to Congress on the prevention and treatment of co-occurring substance abuse disorders and mental disorders. Rockville (MD): Substance Abuse and Mental Health Services Administration; 2002.
58.
ToneattoT.Screening and assessment of co-occurring disorders: Towards a phenomenological approach. Int J Ment Health Addiction. 2008;6(1):37–44.
59.
MueserKTNoordsyDLDrakeRE, Integrated treatment for dual diagnosis. New York (NY): Guilford Press; 2003.
60.
SteadmanHJMulveyEPMonahanJ, Violence by people discharged from acute psychiatric inpatient facilities and by others in the same neighbourhoods. Arch Gen Psychiatry. 1998;55:393–401.
61.
RushBRScottCKDennisML, The interaction of co-occurring psychiatric problems and recovery management checkups. Eval Rev. 2008;32(1):7–38.
62.
ChanY-FDennisMLFunkRR. Prevalence and comorbidity co-occurrence of major internalizing and externalizing disorders among adolescents and adults presenting to substance abuse treatment. J Subst Abuse Treat. 2008;34(1):14–24.
63.
AbramKMTeplinLA. Co-occurring disorders among mentally ill jail detainees. Am Psychol. 1991;46:1036–1045.
64.
MillerRD. Outpatient civil commitment of the mentally ill: An overview and an update. Behav Sci Law. 2005;6(1):99–118.
65.
SteadmanHJNaplesM.Assessing the effectiveness of jail diversion programs for persons with serious mental illness and co-occurring substance use disorders. Behav Sci Law. 2005;23:163–170.
66.
MorrisseyJMeyerP.Extending ACT to criminal justice settings: Applications, evidence, and options [Internet]. Discussion paper presented at the Evidence-based Practice for Justice Involved Individuals: Assertive Community Treatment Expert Panel Meeting sponsored by the National GAINS Center for Systemic Change for Justice-Involved Persons through the Center for Mental Health Services, SAMHSA. Rockville (MA); 2005 [cited Oct. 2, 2007]. Available from: http://gainscenter.samhsa.gov/text/ebp/Papers/ExtendingACTPaper.asp.
67.
McCoyMLRobertsDLHanrahanP, Jail linkage assertive community treatment services for individuals with mental illnesses. Psychiatr Rehabil J. 2004;27(3):243–250.
68.
WeismanRLLambertiJSPriceN.Integrating criminal justice, community health care, and support services for adults with severe mental disorders. Psychiatr Q. 2004;75(1):71–85.
69.
HserY-ILongshoreDAnglinMD. The life course perspective on drug use: A conceptual framework for understanding drug use trajectory and its management. Eval Rev. 2007;31(6):515–547.
70.
HoffRRosenheckRA. Long-term patterns of service use and cost among patients with both psychiatric and substance abuse disorders. Med Care. 1998;36:835–843.
71.
DickeyBAzeniH.Persons with dual diagnosis of substance abuse and major mental illness: Their excess costs of psychiatric care. Am J Public Health. 1996;86:973–977.
